{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:18:26Z","timestamp":1766150306198,"version":"3.48.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Vincristine is an essential chemotherapy agent administered for various pediatric cancers including acute lymphoblastic leukemia (ALL). While multi-agent chemotherapy for pediatric ALL is highly curative, with survival approaching 95%, it carries the risk of irreversible neurocognitive late effects. Vincristine is known to cause peripheral neuropathy, but its relationship to brain toxicity remains understudied. We investigated vincristine-mediated brain toxicity in young mice lacking\n                    <jats:italic>Sarm1<\/jats:italic>\n                    , a gene whose deletion protects against vincristine-induced peripheral neuropathy. Littermate wildtype and knockout mice were randomly assigned to saline or vincristine groups. In vivo MRI was performed from childhood to early adulthood to measure brain structure volumes, followed by ex vivo diffusion tensor imaging (DTI) to assess microstructural changes. In a separate cohort, electron microscopy (EM) quantified axon morphology in the sciatic nerve and corpus callosum. Vincristine induced significant volume reduction across the brain, while\n                    <jats:italic>Sarm1<\/jats:italic>\n                    knockout reduced loss in both grey and white matter. Several regions, including the amygdala and dentate gyrus, showed near-complete recovery in knockouts. DTI revealed limited changes with no genotype differences. EM demonstrated vincristine-induced axon morphology alterations in wildtype mice in both the sciatic nerve and corpus callosum.\n                    <jats:italic>Sarm1<\/jats:italic>\n                    knockout rescued sciatic nerve morphology but not corpus callosum axons. These findings suggest that SARM1-mediated peripheral axon damage may contribute to vincristine-induced brain volume deficits, whereas brain axons may be affected through distinct, SARM1-independent mechanisms. These results suggest a link between vincristine-induced peripheral axon damage and alterations in brain development, with implications for neurocognitive deficits experienced by ALL survivors. Our results suggest that mitigating vincristine-induced peripheral neuropathy may also help reduce neurocognitive deficits in pediatric patients undergoing vincristine treatment.\n                  <\/jats:p>","DOI":"10.1186\/s40478-025-02171-0","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:14:33Z","timestamp":1766150073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vincristine-induced brain toxicity is reduced with prevention of peripheral axon degeneration in Sarm1 knockout mice"],"prefix":"10.1186","volume":"13","author":[{"given":"Jonas","family":"Yeung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prisca","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan","family":"Mak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Darbandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne L.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanna","family":"Weksberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon L.","family":"Guger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell J.","family":"Schachar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann","family":"Hitzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Nieman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"2171_CR1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ejca.2021.09.014","volume":"164","author":"S Barnett","year":"2022","unstructured":"Barnett S, Hellmann F, Parke E, Makin G, Tweddle DA, Osborne C et al (2022) Vincristine dosing, drug exposure and therapeutic drug monitoring in neonate and infant cancer patients. Eur J Cancer 164:127\u2013136. https:\/\/doi.org\/10.1016\/j.ejca.2021.09.014","journal-title":"Eur J Cancer"},{"key":"2171_CR2","doi-asserted-by":"publisher","first-page":"e577","DOI":"10.1038\/bcj.2017.53","volume":"7","author":"T Terwilliger","year":"2017","unstructured":"Terwilliger T, Abdul-Hay M (2017) Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J 7:e577\u2013e577. https:\/\/doi.org\/10.1038\/bcj.2017.53","journal-title":"Blood Cancer J"},{"key":"2171_CR3","doi-asserted-by":"publisher","unstructured":"Hunger SP, Mullighan CG (2015) Acute lymphoblastic leukemia in children. N Engl J Med 373:1541\u20131552. https:\/\/doi.org\/10.1056\/NEJMra1400972","DOI":"10.1056\/NEJMra1400972"},{"key":"2171_CR4","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/ajh.26156","volume":"96","author":"K Sasaki","year":"2021","unstructured":"Sasaki K, Jabbour E, Short NJ, Jain N, Ravandi F, Pui C-H et al (2021) Acute lymphoblastic leukemia: a population-based study of outcome in the United States based on the surveillance, epidemiology, and end results (SEER) database, 1980\u20132017. Am J Hematol 96:650\u2013658. https:\/\/doi.org\/10.1002\/ajh.26156","journal-title":"Am J Hematol"},{"key":"2171_CR5","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1200\/JCO.20.02322","volume":"39","author":"E van der Plas","year":"2021","unstructured":"van der Plas E, Modi AJ, Li CK, Krull KR, Cheung YT (2021) Cognitive impairment in survivors of pediatric acute lymphoblastic leukemia treated with chemotherapy only. JCO 39:1705\u20131717. https:\/\/doi.org\/10.1200\/JCO.20.02322","journal-title":"JCO"},{"key":"2171_CR6","unstructured":"Howlader N, Noone A, Krapcho M, Miller D, Bishop K, Kosary C et al (2017) SEER cancer statistics review. Natl Cancer Inst 1975\u20132014. https:\/\/seer.cancer.gov\/csr\/1975_2014\/"},{"key":"2171_CR7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.neubiorev.2015.03.016","volume":"53","author":"YT Cheung","year":"2015","unstructured":"Cheung YT, Krull KR (2015) Neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia treated on contemporary treatment protocols: a systematic review. Neurosci Biobehav Rev 53:108\u2013120. https:\/\/doi.org\/10.1016\/j.neubiorev.2015.03.016","journal-title":"Neurosci Biobehav Rev"},{"key":"2171_CR8","doi-asserted-by":"publisher","first-page":"e2316077","DOI":"10.1001\/jamanetworkopen.2023.16077","volume":"6","author":"NS Phillips","year":"2023","unstructured":"Phillips NS, Stratton KL, Williams AM, Ahles T, Ness KK, Cohen HJ et al (2023) Late-onset cognitive impairment and modifiable risk factors in adult childhood cancer survivors. JAMA Netw Open 6:e2316077. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.16077","journal-title":"JAMA Netw Open"},{"key":"2171_CR9","first-page":"25","volume":"24","author":"E van der Plas","year":"2015","unstructured":"van der Plas E, Nieman BJ, Butcher DT, Hitzler JK, Weksberg R, Ito S et al (2015) Neurocognitive late effects of chemotherapy in survivors of acute lymphoblastic leukemia: focus on methotrexate. J Can Acad Child Adolesc Psychiatry 24:25\u201332","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"key":"2171_CR10","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/arclin\/15.7.603","volume":"15","author":"M Moleski","year":"2000","unstructured":"Moleski M (2000) Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Arch Clin Neuropsychol 15:603\u2013630","journal-title":"Arch Clin Neuropsychol"},{"key":"2171_CR11","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1200\/JCO.2015.64.3205","volume":"34","author":"LM Jacola","year":"2016","unstructured":"Jacola LM, Krull KR, Pui C-H, Pei D, Cheng C, Reddick WE et al (2016) Longitudinal assessment of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia treated on a contemporary chemotherapy protocol. JCO 34:1239\u20131247. https:\/\/doi.org\/10.1200\/JCO.2015.64.3205","journal-title":"JCO"},{"key":"2171_CR12","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/pbc.20147","volume":"44","author":"M Mennes","year":"2005","unstructured":"Mennes M, Stiers P, Vandenbussche E, Vercruysse G, Uyttebroeck A, Meyer GD et al (2005) Attention and information processing in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. Pediatr Blood Cancer 44:478\u2013486. https:\/\/doi.org\/10.1002\/pbc.20147","journal-title":"Pediatr Blood Cancer"},{"key":"2171_CR13","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1586\/ehm.10.65","volume":"3","author":"WE Reddick","year":"2010","unstructured":"Reddick WE, Conklin HM (2010) Impact of acute lymphoblastic leukemia therapy on attention and working memory in children. Expert Rev Hematol 3:655\u2013659. https:\/\/doi.org\/10.1586\/ehm.10.65","journal-title":"Expert Rev Hematol"},{"key":"2171_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/pbc.25690","volume":"63","author":"A Kanellopoulos","year":"2016","unstructured":"Kanellopoulos A, Andersson S, Zeller B, Tamnes CK, Fjell AM, Walhovd KB et al (2016) Neurocognitive outcome in very long-term survivors of childhood acute lymphoblastic leukemia after treatment with chemotherapy only. Pediatr Blood Cancer 63:133\u2013138. https:\/\/doi.org\/10.1002\/pbc.25690","journal-title":"Pediatr Blood Cancer"},{"key":"2171_CR15","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/S2215-0366(16)30283-8","volume":"3","author":"LM Jacola","year":"2016","unstructured":"Jacola LM, Edelstein K, Liu W, Pui C-H, Hayashi R, Kadan-Lottick NS et al (2016) Cognitive, behaviour, and academic functioning in adolescent and young adult survivors of childhood acute lymphoblastic leukaemia: a report from the childhood cancer survivor study. Lancet Psychiatry 3:965\u2013972. https:\/\/doi.org\/10.1016\/S2215-0366(16)30283-8","journal-title":"Lancet Psychiatry"},{"key":"2171_CR16","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1093\/jpepsy\/jsr119","volume":"37","author":"LA Harshman","year":"2012","unstructured":"Harshman LA, Barron S, Button AM, Smith BJ, Link BK, Lynch CF et al (2012) Population-based exploration of academic achievement outcomes in pediatric acute lymphoblastic leukemia survivors. J Pediatr Psychol 37:458\u2013466. https:\/\/doi.org\/10.1093\/jpepsy\/jsr119","journal-title":"J Pediatr Psychol"},{"key":"2171_CR17","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41390-020-01230-7","volume":"90","author":"E van der Plas","year":"2020","unstructured":"van der Plas E, Spencer Noakes TL, Butcher DT, Weksberg R, Galin-Corini L, Wanstall EA et al (2020) Cognitive and behavioral risk factors for low quality of life in survivors of childhood acute lymphoblastic leukemia. Pediatr Res 90:419\u2013426. https:\/\/doi.org\/10.1038\/s41390-020-01230-7","journal-title":"Pediatr Res"},{"key":"2171_CR18","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/pon.3470","volume":"23","author":"A Kunin-Batson","year":"2014","unstructured":"Kunin-Batson A, Kadan-Lottick N, Neglia JP (2014) The contribution of neurocognitive functioning to quality of life after childhood acute lymphoblastic leukemia. Psycho-oncology 23:692\u2013699. https:\/\/doi.org\/10.1002\/pon.3470","journal-title":"Psycho-oncology"},{"key":"2171_CR19","doi-asserted-by":"publisher","first-page":"6040","DOI":"10.1158\/1078-0432.CCR-18-0551","volume":"24","author":"TL Spencer Noakes","year":"2018","unstructured":"Spencer Noakes TL, Przybycien TS, Forwell A, Nicholls C, Zhou Y-Q, Butcher DT et al (2018) Brain development and heart function after systemic single-agent chemotherapy in a mouse model of childhood leukemia treatment. Clin Cancer Res 24:6040\u20136052. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-0551","journal-title":"Clin Cancer Res"},{"key":"2171_CR20","doi-asserted-by":"publisher","first-page":"102428","DOI":"10.1016\/j.nicl.2020.102428","volume":"28","author":"E van der Plas","year":"2020","unstructured":"van der Plas E, Spencer Noakes TL, Butcher DT, Weksberg R, Galin-Corini L, Wanstall EA et al (2020) Quantitative MRI outcomes in child and adolescent leukemia survivors: evidence for global alterations in Gray and white matter. NeuroImage Clin 28:102428. https:\/\/doi.org\/10.1016\/j.nicl.2020.102428","journal-title":"NeuroImage: Clin"},{"key":"2171_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1136\/jnnp.32.4.297","volume":"32","author":"JG McLeod","year":"1969","unstructured":"McLeod JG, Penny R (1969) Vincristine neuropathy: an electrophysiological and histological study. J Neurol Neurosurg Psychiatry 32:297\u2013304. https:\/\/doi.org\/10.1136\/jnnp.32.4.297","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2171_CR22","first-page":"3591","volume":"43","author":"H Mujagic","year":"1983","unstructured":"Mujagic H, Chen SS, Geist R, Occhipinti SJ, Conger BM, Smith CA et al (1983) Effects of vincristine on cell survival, cell cycle progression, and mitotic accumulation in asynchronously growing sarcoma 180 cells. Cancer Res 43:3591\u20133597","journal-title":"Cancer Res"},{"key":"2171_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1529-8027.2006.0090.x","volume":"11","author":"A Silva","year":"2006","unstructured":"Silva A, Wang Q, Wang M, Ravula SK, Glass JD (2006) Evidence for direct axonal toxicity in vincristine neuropathy. J Peripher Nerv Syst 11:211\u2013216. https:\/\/doi.org\/10.1111\/j.1529-8027.2006.0090.x","journal-title":"J Peripher Nerv Syst"},{"key":"2171_CR24","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1529-8027.2009.00230.x","volume":"14","author":"S Ramchandren","year":"2009","unstructured":"Ramchandren S, Leonard M, Mody RJ, Donohue JE, Moyer J, Hutchinson R et al (2009) Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia. J Peripheral Nerv Syst 14:184\u2013189. https:\/\/doi.org\/10.1111\/j.1529-8027.2009.00230.x","journal-title":"J Peripheral Nerv Syst"},{"key":"2171_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/jns.12114","volume":"20","author":"EM Lavoie Smith","year":"2015","unstructured":"Lavoie Smith EM, Li L, Chiang C, Thomas K, Hutchinson RJ, Wells EM et al (2015) Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia. J Peripher Nerv Syst 20:37\u201346. https:\/\/doi.org\/10.1111\/jns.12114","journal-title":"J Peripher Nerv Syst"},{"key":"2171_CR26","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1002\/cncr.10397","volume":"94","author":"SJ Kellie","year":"2002","unstructured":"Kellie SJ, Barbaric D, Koopmans P, Earl J, Carr DJ, de Graaf SSN (2002) Cerebrospinal fluid concentrations of vincristine after bolus intravenous dosing: a surrogate marker of brain penetration. Cancer 94:1815\u20131820. https:\/\/doi.org\/10.1002\/cncr.10397","journal-title":"Cancer"},{"key":"2171_CR27","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1021\/jm00180a022","volume":"23","author":"VA Levin","year":"1980","unstructured":"Levin VA (1980) Relationship of octanol\/water partition coefficient and molecular weight to rat brain capillary permeability. J Med Chem 23:682\u2013684. https:\/\/doi.org\/10.1021\/jm00180a022","journal-title":"J Med Chem"},{"key":"2171_CR28","doi-asserted-by":"publisher","first-page":"20383","DOI":"10.1016\/S0021-9258(19)88713-6","volume":"267","author":"T Tatsuta","year":"1992","unstructured":"Tatsuta T, Naito M, Oh-hara T, Sugawara I, Tsuruo T (1992) Functional involvement of P-glycoprotein in blood-brain barrier. J Biol Chem 267:20383\u201320391","journal-title":"J Biol Chem"},{"key":"2171_CR29","doi-asserted-by":"publisher","first-page":"13569","DOI":"10.1523\/JNEUROSCI.1197-13.2013","volume":"33","author":"J Gerdts","year":"2013","unstructured":"Gerdts J, Summers DW, Sasaki Y, DiAntonio A, Milbrandt J (2013) Sarm1-mediated axon degeneration requires both SAM and TIR interactions. J Neurosci 33:13569\u201313580. https:\/\/doi.org\/10.1523\/JNEUROSCI.1197-13.2013","journal-title":"J Neurosci"},{"key":"2171_CR30","doi-asserted-by":"publisher","first-page":"102884","DOI":"10.1016\/j.conb.2024.102884","volume":"87","author":"S Geisler","year":"2024","unstructured":"Geisler S (2024) Augustus waller\u2019s foresight realized: SARM1 in peripheral neuropathies. Curr Opin Neurobiol 87:102884. https:\/\/doi.org\/10.1016\/j.conb.2024.102884","journal-title":"Curr Opin Neurobiol"},{"key":"2171_CR31","doi-asserted-by":"publisher","first-page":"9240","DOI":"10.1007\/s12035-025-04835-3","volume":"62","author":"A Karnik","year":"2025","unstructured":"Karnik A, Joshi A (2025) SARM1: the checkpoint of axonal degeneration in the nervous system disorders. Mol Neurobiol 62:9240\u20139257. https:\/\/doi.org\/10.1007\/s12035-025-04835-3","journal-title":"Mol Neurobiol"},{"key":"2171_CR32","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1126\/science.1258366","volume":"348","author":"J Gerdts","year":"2015","unstructured":"Gerdts J, Brace EJ, Sasaki Y, DiAntonio A, Milbrandt J (2015) SARM1 activation triggers axon degeneration locally via NAD+ destruction. Science 348:453\u2013457. https:\/\/doi.org\/10.1126\/science.1258366","journal-title":"Science"},{"key":"2171_CR33","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.neuron.2015.12.023","volume":"89","author":"J Gerdts","year":"2016","unstructured":"Gerdts J, Summers DW, Milbrandt J, DiAntonio A (2016) Axon self-destruction: new links among SARM1, MAPKs, and NAD\u2009+\u2009Metabolism. Neuron 89:449\u2013460. https:\/\/doi.org\/10.1016\/j.neuron.2015.12.023","journal-title":"Neuron"},{"key":"2171_CR34","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1093\/brain\/aww251","volume":"139","author":"S Geisler","year":"2016","unstructured":"Geisler S, Doan RA, Strickland A, Huang X, Milbrandt J, DiAntonio A (2016) Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice. Brain 139:3092\u20133108. https:\/\/doi.org\/10.1093\/brain\/aww251","journal-title":"Brain"},{"key":"2171_CR35","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1002\/cpmo.44","volume":"8","author":"BJ Nieman","year":"2018","unstructured":"Nieman BJ, van Eede MC, Spring S, Dazai J, Henkelman RM, Lerch JP (2018) MRI to assess neurological function. Curr Protocols Mouse Biol 8:e44. https:\/\/doi.org\/10.1002\/cpmo.44","journal-title":"Curr Protocols Mouse Biology"},{"key":"2171_CR36","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1097\/j.pain.0000000000002485","volume":"163","author":"M Partanen","year":"2022","unstructured":"Partanen M, Alberts NM, Conklin HM, Krull KR, Pui C-H, Anghelescu DA et al (2022) Neuropathic pain and neurocognitive functioning in children treated for acute lymphoblastic leukemia. Pain 163:1070\u20131077. https:\/\/doi.org\/10.1097\/j.pain.0000000000002485","journal-title":"Pain"},{"key":"2171_CR37","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1084\/jem.20070868","volume":"204","author":"Y Kim","year":"2007","unstructured":"Kim Y, Zhou P, Qian L, Chuang J-Z, Lee J, Li C et al (2007) MyD88-5 links mitochondria, microtubules, and JNK3 in neurons and regulates neuronal survival. J Exp Med 204:2063\u20132074. https:\/\/doi.org\/10.1084\/jem.20070868","journal-title":"J Exp Med"},{"key":"2171_CR38","doi-asserted-by":"publisher","first-page":"119008","DOI":"10.1016\/j.neuroimage.2022.119008","volume":"252","author":"A Arbabi","year":"2022","unstructured":"Arbabi A, Spencer Noakes L, Vousden D, Dazai J, Spring S, Botelho O et al (2022) Multiple-mouse magnetic resonance imaging with cryogenic radiofrequency probes for evaluation of brain development. NeuroImage 252:119008. https:\/\/doi.org\/10.1016\/j.neuroimage.2022.119008","journal-title":"NeuroImage"},{"key":"2171_CR39","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/nbm.932","volume":"17","author":"YZ Wadghiri","year":"2004","unstructured":"Wadghiri YZ, Blind JA, Duan X, Moreno C, Yu X, Joyner AL et al (2004) Manganese-enhanced magnetic resonance imaging (MEMRI) of mouse brain development. NMR Biomed 17:613\u2013619. https:\/\/doi.org\/10.1002\/nbm.932","journal-title":"NMR Biomed"},{"key":"2171_CR40","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1002\/mrm.21945","volume":"61","author":"BJ Nieman","year":"2009","unstructured":"Nieman BJ, Szulc KU, Turnbull DH (2009) Three-dimensional, in vivo MRI with self-gating and image coregistration in the mouse. Magn Reson Med 61:1148\u20131157. https:\/\/doi.org\/10.1002\/mrm.21945","journal-title":"Magn Reson Med"},{"key":"2171_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fninf.2014.00067","author":"M Friedel","year":"2014","unstructured":"Friedel M, van Eede MC, Pipitone J, Chakravarty MM, Lerch JP (2014) Pydpiper: a flexible toolkit for constructing novel registration pipelines. Front Neuroinform. 8 https:\/\/doi.org\/10.3389\/fninf.2014.00067","journal-title":"Front Neuroinform [Internet]"},{"key":"2171_CR42","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neuroimage.2008.03.037","volume":"42","author":"AE Dorr","year":"2008","unstructured":"Dorr AE, Lerch JP, Spring S, Kabani N, Henkelman RM (2008) High resolution three-dimensional brain atlas using an average magnetic resonance image of 40 adult C57Bl\/6J mice. NeuroImage 42:60\u201369. https:\/\/doi.org\/10.1016\/j.neuroimage.2008.03.037","journal-title":"NeuroImage"},{"key":"2171_CR43","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.neuroimage.2011.06.025","volume":"58","author":"K Richards","year":"2011","unstructured":"Richards K, Watson C, Buckley RF, Kurniawan ND, Yang Z, Keller MD et al (2011) Segmentation of the mouse hippocampal formation in magnetic resonance images. NeuroImage 58:732\u2013740. https:\/\/doi.org\/10.1016\/j.neuroimage.2011.06.025","journal-title":"NeuroImage"},{"key":"2171_CR44","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/aur.1344","volume":"7","author":"PE Steadman","year":"2014","unstructured":"Steadman PE, Ellegood J, Szulc KU, Turnbull DH, Joyner AL, Henkelman RM et al (2014) Genetic effects on cerebellar structure across mouse models of autism using a magnetic resonance imaging atlas: MRI of genetic mouse model\u2019s cerebellum. Autism Res 7:124\u2013137. https:\/\/doi.org\/10.1002\/aur.1344","journal-title":"Autism Res"},{"key":"2171_CR45","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.neuroimage.2013.04.008","volume":"78","author":"JFP Ullmann","year":"2013","unstructured":"Ullmann JFP, Watson C, Janke AL, Kurniawan ND, Reutens DC (2013) A segmentation protocol and MRI atlas of the C57BL\/6J mouse neocortex. NeuroImage 78:196\u2013203. https:\/\/doi.org\/10.1016\/j.neuroimage.2013.04.008","journal-title":"NeuroImage"},{"key":"2171_CR46","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1002\/hbm.22092","volume":"34","author":"MM Chakravarty","year":"2013","unstructured":"Chakravarty MM, Steadman P, van Eede MC, Calcott RD, Gu V, Shaw P et al (2013) Performing label-fusion-based segmentation using multiple automatically generated templates. Hum Brain Mapp 34:2635\u20132654. https:\/\/doi.org\/10.1002\/hbm.22092","journal-title":"Hum Brain Mapp"},{"key":"2171_CR47","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.neuroimage.2012.01.100","volume":"60","author":"LS Cahill","year":"2012","unstructured":"Cahill LS, Lalibert\u00e9 CL, Ellegood J, Spring S, Gleave JA, van Eede MC et al (2012) Preparation of fixed mouse brains for MRI. NeuroImage 60:933\u2013939. https:\/\/doi.org\/10.1016\/j.neuroimage.2012.01.100","journal-title":"NeuroImage"},{"key":"2171_CR48","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.neuroimage.2016.06.028","volume":"142","author":"AE de Guzman","year":"2016","unstructured":"de Guzman AE, Wong MD, Gleave JA, Nieman BJ (2016) Variations in post-perfusion immersion fixation and storage alter MRI measurements of mouse brain morphometry. NeuroImage 142:687\u2013695. https:\/\/doi.org\/10.1016\/j.neuroimage.2016.06.028","journal-title":"NeuroImage"},{"key":"2171_CR49","unstructured":"Andersen M, Dahl J, Vandenberghe LCVXOPT (2020) Convex optimization. Astrophys Source Code Libr ascl:2008.017. https:\/\/ui.adsabs.harvard.edu\/abs\/2020ascl.soft08017A"},{"key":"2171_CR50","doi-asserted-by":"publisher","first-page":"101304","DOI":"10.1016\/j.xpro.2022.101304","volume":"3","author":"Y Wang","year":"2022","unstructured":"Wang Y, Sun B, Shibata B, Guo F (2022) Transmission electron microscopic analysis of myelination in the murine central nervous system. STAR Protoc 3:101304. https:\/\/doi.org\/10.1016\/j.xpro.2022.101304","journal-title":"STAR Protoc"},{"key":"2171_CR51","doi-asserted-by":"publisher","unstructured":"Zaimi A, Wabartha M, Herman V, Antonsanti P-L, Perone CS, Cohen-Adad J (2018) AxonDeepSeg: automatic axon and myelin segmentation from microscopy data using convolutional neural networks. Sci Rep 8:3816. https:\/\/doi.org\/10.1038\/s41598-018-22181-4","DOI":"10.1038\/s41598-018-22181-4"},{"key":"2171_CR52","doi-asserted-by":"publisher","unstructured":"Bates D, M\u00e4chler M, Bolker B, Walker S (2015) Fitting linear Mixed-effects models using lme4. J Stat Soft 67. https:\/\/doi.org\/10.18637\/jss.v067.i01","DOI":"10.18637\/jss.v067.i01"},{"key":"2171_CR53","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc: Ser B (Methodol) 57:289\u2013300. https:\/\/doi.org\/10.1111\/j.2517-6161.1995.tb02031.x","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"key":"2171_CR54","doi-asserted-by":"publisher","first-page":"e5015","DOI":"10.1002\/nbm.5015","volume":"36","author":"K Szulc-Lerch","year":"2023","unstructured":"Szulc-Lerch K, Yeung J, de Guzman AE, Egan S, Yee Y, Fernandes D et al (2023) Exercise promotes growth and rescues volume deficits in the hippocampus after cranial radiation in young mice. NMR Biomed 36:e5015. https:\/\/doi.org\/10.1002\/nbm.5015","journal-title":"NMR Biomed"},{"key":"2171_CR55","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41583-019-0260-z","volume":"21","author":"T Hainmueller","year":"2020","unstructured":"Hainmueller T, Bartos M (2020) Dentate gyrus circuits for encoding, retrieval and discrimination of episodic memories. Nat Rev Neurosci 21:153\u2013168. https:\/\/doi.org\/10.1038\/s41583-019-0260-z","journal-title":"Nat Rev Neurosci"},{"key":"2171_CR56","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/jnen\/59.7.599","volume":"59","author":"M-S Wang","year":"2000","unstructured":"Wang M-S, Wu Y, Culver DG, Glass JD (2000) Pathogenesis of axonal degeneration: parallels between wallerian degeneration and vincristine neuropathy. J Neuropathol Exp Neurol 59:599\u2013606. https:\/\/doi.org\/10.1093\/jnen\/59.7.599","journal-title":"J Neuropathol Exp Neurol"},{"key":"2171_CR57","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.1038\/srep06370","volume":"4","author":"W Boehmerle","year":"2014","unstructured":"Boehmerle W, Huehnchen P, Peruzzaro S, Balkaya M, Endres M (2014) Electrophysiological, behavioral and histological characterization of paclitaxel, cisplatin, vincristine and bortezomib-induced neuropathy in C57Bl\/6 mice. Sci Rep 4:6370. https:\/\/doi.org\/10.1038\/srep06370","journal-title":"Sci Rep"},{"key":"2171_CR58","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1215\/S1152851703000516","volume":"6","author":"FM Boyle","year":"2004","unstructured":"Boyle FM, Eller SL, Grossman SA (2004) Penetration of intra-arterially administered vincristine in experimental brain tumor. Neuro Oncol 6:300\u2013305. https:\/\/doi.org\/10.1215\/S1152851703000516","journal-title":"Neuro Oncol"},{"key":"2171_CR59","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1200\/JCO.1994.12.4.740","volume":"12","author":"MA Schorin","year":"1994","unstructured":"Schorin MA, Blattner S, Gelber RD, Tarbell NJ, Donnelly M, Dalton V et al (1994) Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber cancer Institute\/Children\u2019s hospital acute lymphoblastic leukemia consortium protocol 85\u2009\u2013\u200901. JCO 12:740\u2013747. https:\/\/doi.org\/10.1200\/JCO.1994.12.4.740","journal-title":"JCO"},{"key":"2171_CR60","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/pbc.24947","volume":"61","author":"WE Reddick","year":"2014","unstructured":"Reddick WE, Taghipour DJ, Glass JO, Ashford J, Xiong X, Wu S et al (2014) Prognostic factors that increase the risk for reduced white matter volumes and deficits in attention and learning for survivors of childhood cancers: reduced WMV in childhood cancer survivors. Pediatr Blood Cancer 61:1074\u20131079. https:\/\/doi.org\/10.1002\/pbc.24947","journal-title":"Pediatr Blood Cancer"},{"key":"2171_CR61","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/pbc.25386","volume":"62","author":"CK Tamnes","year":"2015","unstructured":"Tamnes CK, Zeller B, Amlien IK, Kanellopoulos A, Andersson S, Due-T\u00f8nnessen P et al (2015) Cortical surface area and thickness in adult survivors of pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer 62:1027\u20131034. https:\/\/doi.org\/10.1002\/pbc.25386","journal-title":"Pediatr Blood Cancer"},{"key":"2171_CR62","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.brainres.2017.01.017","volume":"1658","author":"L Zou","year":"2017","unstructured":"Zou L, Su L, Xu J, Xiang L, Wang L, Zhai Z et al (2017) Structural brain alteration in survivors of acute lymphoblastic leukemia with chemotherapy treatment: a voxel-based morphometry and diffusion tensor imaging study. Brain Res 1658:68\u201372. https:\/\/doi.org\/10.1016\/j.brainres.2017.01.017","journal-title":"Brain Res"},{"key":"2171_CR63","doi-asserted-by":"publisher","first-page":"pkab069","DOI":"10.1093\/jncics\/pkab069","volume":"5","author":"K Gandy","year":"2021","unstructured":"Gandy K, Scoggins MA, Jacola LM, Litten M, Reddick WE, Krull KR (2021) Structural and functional brain imaging in long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy: a systematic review. JNCI Cancer Spectr 5:pkab069. https:\/\/doi.org\/10.1093\/jncics\/pkab069","journal-title":"JNCI Cancer Spectr"},{"key":"2171_CR64","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nrc2073","volume":"7","author":"TA Ahles","year":"2007","unstructured":"Ahles TA, Saykin AJ (2007) Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 7:192\u2013201. https:\/\/doi.org\/10.1038\/nrc2073","journal-title":"Nat Rev Cancer"},{"key":"2171_CR65","doi-asserted-by":"publisher","first-page":"673340","DOI":"10.3389\/fonc.2021.673340","volume":"11","author":"J Du","year":"2021","unstructured":"Du J, Zhang A, Li J, Liu X, Wu S, Wang B et al (2021) Doxorubicin-Induced cognitive impairment: the mechanistic insights. Front Oncol 11:673340. https:\/\/doi.org\/10.3389\/fonc.2021.673340","journal-title":"Front Oncol"},{"key":"2171_CR66","doi-asserted-by":"publisher","first-page":"173078","DOI":"10.1016\/j.ejphar.2020.173078","volume":"881","author":"S Eide","year":"2020","unstructured":"Eide S, Feng Z-P (2020) Doxorubicin chemotherapy-induced chemo-brain: meta-analysis. Eur J Pharmacol 881:173078. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173078","journal-title":"Eur J Pharmacol"},{"key":"2171_CR67","first-page":"1827","volume":"36","author":"IH Plenderleith","year":"1990","unstructured":"Plenderleith IH (1990) Treating the treatment: toxicity of cancer chemotherapy. Can Fam Phys 36:1827\u20131830","journal-title":"Can Fam Physician"},{"key":"2171_CR68","unstructured":"Awosika AO, Below J, Das JM Vincristine (2024) StatPearls. StatPearls Publishing, Treasure Island (FL). http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537122\/. Accessed 19 Oct 2024"},{"key":"2171_CR69","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","volume":"65","author":"O Tacar","year":"2013","unstructured":"Tacar O, Sriamornsak P, Dass CR (2013) Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol 65:157\u2013170. https:\/\/doi.org\/10.1111\/j.2042-7158.2012.01567.x","journal-title":"J Pharm Pharmacol"},{"key":"2171_CR70","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.bbi.2025.06.034","volume":"129","author":"J Yeung","year":"2025","unstructured":"Yeung J, Quach H, Wong AP, Wheeler AL, Weksberg R, Guger SL et al (2025) Il-6 knockout reduces doxorubicin-induced toxicity in the developing mouse brain. Brain Behav Immun 129:609\u2013619. https:\/\/doi.org\/10.1016\/j.bbi.2025.06.034","journal-title":"Brain Behav Immun"},{"key":"2171_CR71","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s43018-024-00745-w","volume":"5","author":"JL Guida","year":"2024","unstructured":"Guida JL, Hyun G, Belsky DW, Armstrong GT, Ehrhardt MJ, Hudson MM et al (2024) Associations of seven measures of biological age acceleration with frailty and all-cause mortality among adult survivors of childhood cancer in the St. Jude lifetime cohort. Nat Cancer 5:731\u2013741. https:\/\/doi.org\/10.1038\/s43018-024-00745-w","journal-title":"Nat Cancer"},{"key":"2171_CR72","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/BF03259853","volume":"1","author":"SS Legha","year":"1986","unstructured":"Legha SS (1986) Vincristine neurotoxicity: pathophysiology and management. Med Toxicol 1:421\u2013427. https:\/\/doi.org\/10.1007\/BF03259853","journal-title":"Med Toxicol"},{"key":"2171_CR73","doi-asserted-by":"publisher","first-page":"4187","DOI":"10.7150\/thno.49054","volume":"11","author":"H Liu","year":"2021","unstructured":"Liu H, Zhang J, Xu X, Lu S, Yang D, Xie C et al (2021) SARM1 promotes neuroinflammation and inhibits neural regeneration after spinal cord injury through NF-\u03baB signaling. Theranostics 11:4187\u20134206. https:\/\/doi.org\/10.7150\/thno.49054","journal-title":"Theranostics"},{"key":"2171_CR74","doi-asserted-by":"publisher","first-page":"147","DOI":"10.5625\/lar.2018.34.4.147","volume":"34","author":"H Kim","year":"2018","unstructured":"Kim H, Kim M, Im S-K, Fang S (2018) Mouse Cre-LoxP system: general principles to determine tissue-specific roles of target genes. Lab Anim Res 34:147\u2013159. https:\/\/doi.org\/10.5625\/lar.2018.34.4.147","journal-title":"Lab Anim Res"},{"key":"2171_CR75","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1111\/ejn.12007","volume":"36","author":"MS Nokia","year":"2012","unstructured":"Nokia MS, Anderson ML, Shors TJ (2012) Chemotherapy disrupts learning, neurogenesis and theta activity in the adult brain. Eur J Neurosci 36:3521\u20133530. https:\/\/doi.org\/10.1111\/ejn.12007","journal-title":"Eur J Neurosci"},{"key":"2171_CR76","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1158\/1078-0432.CCR-11-2000","volume":"18","author":"L-A Christie","year":"2012","unstructured":"Christie L-A, Acharya MM, Parihar VK, Nguyen A, Martirosian V, Limoli CL (2012) Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy. Clin Cancer Res 18:1954\u20131965. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-2000","journal-title":"Clin Cancer Res"},{"key":"2171_CR77","doi-asserted-by":"publisher","first-page":"e27470","DOI":"10.1002\/pbc.27470","volume":"66","author":"HA Marusak","year":"2019","unstructured":"Marusak HA, Iadipaolo AS, Paulisin S, Harper FW, Taub JW, Dulay K et al (2019) Emotion-related brain organization and behavioral responses to socioemotional stimuli in pediatric cancer survivors with posttraumatic stress symptoms. Pediatr Blood Cancer 66:e27470. https:\/\/doi.org\/10.1002\/pbc.27470","journal-title":"Pediatr Blood Cancer"},{"key":"2171_CR78","doi-asserted-by":"publisher","first-page":"e00621","DOI":"10.1002\/brb3.621","volume":"7","author":"E van der Plas","year":"2017","unstructured":"van der Plas E, Schachar RJ, Hitzler J, Crosbie J, Guger SL, Spiegler BJ et al (2017) Brain structure, working memory and response Inhibition in childhood leukemia survivors. Brain Behav 7:e00621. https:\/\/doi.org\/10.1002\/brb3.621","journal-title":"Brain Behav"},{"key":"2171_CR79","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/jnci\/djy009","volume":"110","author":"T Billiet","year":"2018","unstructured":"Billiet T, Elens I, Sleurs C, Uyttebroeck A, D\u2019Hooge R, Lemiere J et al (2018) Brain connectivity and cognitive flexibility in nonirradiated adult survivors of childhood leukemia. JNCI J Natl Cancer Inst 110:905\u2013913. https:\/\/doi.org\/10.1093\/jnci\/djy009","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"2171_CR80","doi-asserted-by":"publisher","first-page":"e456","DOI":"10.1016\/S2352-3026(16)30110-7","volume":"3","author":"YT Cheung","year":"2016","unstructured":"Cheung YT, Sabin ND, Reddick WE, Bhojwani D, Liu W, Brinkman TM et al (2016) Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis. Lancet Haematol 3:e456\u2013e466. https:\/\/doi.org\/10.1016\/S2352-3026(16)30110-7","journal-title":"Lancet Haematol"},{"key":"2171_CR81","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3109\/08880018.2013.871763","volume":"31","author":"M ElAlfy","year":"2014","unstructured":"ElAlfy M, Ragab I, Azab I, Amin S, Abdel-Maguid M (2014) Neurocognitive outcome and white matter anisotropy in childhood acute lymphoblastic leukemia survivors treated with different protocols. Pediatr Hematol Oncol 31:194\u2013204. https:\/\/doi.org\/10.3109\/08880018.2013.871763","journal-title":"Pediatr Hematol Oncol"},{"key":"2171_CR82","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1002\/cncr.31379","volume":"124","author":"DJ Zheng","year":"2018","unstructured":"Zheng DJ, Krull KR, Chen Y, Diller L, Yasui Y, Leisenring W et al (2018) Long-term psychological and educational outcomes for survivors of neuroblastoma: a report from the childhood cancer survivor study. Cancer 124:3220\u20133230. https:\/\/doi.org\/10.1002\/cncr.31379","journal-title":"Cancer"},{"key":"2171_CR83","doi-asserted-by":"publisher","first-page":"101765","DOI":"10.1016\/j.jgo.2024.101765","volume":"15","author":"BL McNeish","year":"2024","unstructured":"McNeish BL, Dittus K, Mossburg J, Krant N, Steinharter JA, Feb K et al (2024) The association of chemotherapy-induced peripheral neuropathy with reduced executive function in chemotherapy-treated cancer survivors: a cross-sectional study. J Geriatric Oncol 15:101765. https:\/\/doi.org\/10.1016\/j.jgo.2024.101765","journal-title":"J Geriatric Oncol"},{"key":"2171_CR84","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1200\/JCO.2017.76.7871","volume":"36","author":"M Varedi","year":"2018","unstructured":"Varedi M, Lu L, Howell CR, Partin RE, Hudson MM, Pui C-H et al (2018) Peripheral neuropathy, sensory Processing, and balance in survivors of acute lymphoblastic leukemia. JCO 36:2315\u20132322. https:\/\/doi.org\/10.1200\/JCO.2017.76.7871","journal-title":"JCO"},{"key":"2171_CR85","doi-asserted-by":"publisher","first-page":"10054","DOI":"10.1200\/JCO.2023.41.16_suppl.10054","volume":"41","author":"A Williams","year":"2023","unstructured":"Williams A, Phillips NS, Goodenough CG, Brinkman TM, Papini C, Jacola LM et al (2023) Longitudinal associations between peripheral neuropathy and neurocognitive decline in long-term survivors of pediatric cancer treated without central nervous system (CNS) directed therapy. JCO 41:10054\u201310054. https:\/\/doi.org\/10.1200\/JCO.2023.41.16_suppl.10054","journal-title":"JCO"},{"key":"2171_CR86","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/pbc.24255","volume":"60","author":"TM Brinkman","year":"2013","unstructured":"Brinkman TM, Zhang N, Ullrich NJ, Brouwers P, Green DM, Srivastava DK et al (2013) Psychoactive medication use and neurocognitive function in adult survivors of childhood cancer: a report from the childhood cancer survivor study. Pediatr Blood Cancer 60:486\u2013493. https:\/\/doi.org\/10.1002\/pbc.24255","journal-title":"Pediatr Blood Cancer"},{"key":"2171_CR87","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s40122-017-0088-z","volume":"6","author":"R Torta","year":"2017","unstructured":"Torta R, Ieraci V, Zizzi F (2017) A review of the emotional aspects of neuropathic pain: from comorbidity to co-pathogenesis. Pain Ther 6:11\u201317. https:\/\/doi.org\/10.1007\/s40122-017-0088-z","journal-title":"Pain Ther"},{"key":"2171_CR88","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1097\/j.pain.0000000000001838","volume":"161","author":"SN Raja","year":"2020","unstructured":"Raja SN, Ringkamp M, Guan Y, Campbell JN, John J (2020) Bonica award lecture: peripheral neuronal hyperexcitability: the low-hanging target for safe therapeutic strategies in neuropathic pain. Pain 161:S14\u201326. https:\/\/doi.org\/10.1097\/j.pain.0000000000001838","journal-title":"Pain"},{"key":"2171_CR89","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.brainres.2011.06.022","volume":"1405","author":"CF Kim","year":"2011","unstructured":"Kim CF, Moalem-Taylor G (2011) Detailed characterization of neuro-immune responses following neuropathic injury in mice. Brain Res 1405:95\u2013108. https:\/\/doi.org\/10.1016\/j.brainres.2011.06.022","journal-title":"Brain Res"},{"key":"2171_CR90","doi-asserted-by":"publisher","first-page":"626687","DOI":"10.3389\/fimmu.2020.626687","volume":"11","author":"G Fumagalli","year":"2021","unstructured":"Fumagalli G, Monza L, Cavaletti G, Rigolio R, Meregalli C (2021) Neuroinflammatory process involved in different preclinical models of chemotherapy-Induced peripheral neuropathy. Front Immunol 11:626687. https:\/\/doi.org\/10.3389\/fimmu.2020.626687","journal-title":"Front Immunol"},{"key":"2171_CR91","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0006-8993(00)01965-X","volume":"859","author":"WC Covey","year":"2000","unstructured":"Covey WC, Ignatowski TA, Knight PR, Spengler RN (2000) Brain-derived TNF\u03b1: involvement in neuroplastic changes implicated in the conscious perception of persistent pain. Brain Res 859:113\u2013122. https:\/\/doi.org\/10.1016\/S0006-8993(00)01965-X","journal-title":"Brain Res"},{"key":"2171_CR92","doi-asserted-by":"publisher","first-page":"e20201452","DOI":"10.1084\/jem.20201452","volume":"218","author":"H Starobova","year":"2021","unstructured":"Starobova H, Monteleone M, Adolphe C, Batoon L, Sandrock CJ, Tay B et al (2021) Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1\u03b2 release. J Exp Med 218:e20201452. https:\/\/doi.org\/10.1084\/jem.20201452","journal-title":"J Exp Med"},{"key":"2171_CR93","doi-asserted-by":"publisher","first-page":"174480691664678","DOI":"10.1177\/1744806916646784","volume":"12","author":"W-S Gui","year":"2016","unstructured":"Gui W-S, Wei X, Mai C-L, Murugan M, Wu L-J, Xin W-J et al (2016) Interleukin-1\u03b2 overproduction is a common cause for neuropathic pain, memory deficit, and depression following peripheral nerve injury in rodents. Mol Pain 12:1744806916646784. https:\/\/doi.org\/10.1177\/1744806916646784","journal-title":"Mol Pain"},{"key":"2171_CR94","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2147\/JPR.S53660","volume":"6","author":"AK Clark","year":"2013","unstructured":"Clark AK, Old EA, Malcangio M (2013) Neuropathic pain and cytokines: current perspectives. J Pain Res 6:803\u2013814. https:\/\/doi.org\/10.2147\/JPR.S53660","journal-title":"J Pain Res"},{"key":"2171_CR95","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.bbi.2009.12.007","volume":"24","author":"KJ Whitehead","year":"2010","unstructured":"Whitehead KJ, Smith CGS, Delaney S-A, Curnow SJ, Salmon M, Hughes JP et al (2010) Dynamic regulation of spinal pro-inflammatory cytokine release in the rat in vivo following peripheral nerve injury. Brain Behav Immun 24:569\u2013576. https:\/\/doi.org\/10.1016\/j.bbi.2009.12.007","journal-title":"Brain Behav Immun"},{"key":"2171_CR96","doi-asserted-by":"publisher","first-page":"12304","DOI":"10.1523\/JNEUROSCI.0312-14.2014","volume":"34","author":"EL Dimitrov","year":"2014","unstructured":"Dimitrov EL, Tsuda MC, Cameron HA, Usdin TB (2014) Anxiety- and depression-like behavior and impaired neurogenesis evoked by peripheral neuropathy persist following resolution of prolonged tactile hypersensitivity. J Neurosci 34:12304\u201312312. https:\/\/doi.org\/10.1523\/JNEUROSCI.0312-14.2014","journal-title":"J Neurosci"},{"key":"2171_CR97","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1523\/JNEUROSCI.1341-18.2019","volume":"39","author":"MJ Kool","year":"2019","unstructured":"Kool MJ, Proietti Onori M, Borgesius NZ, van de Bree JE, Elgersma-Hooisma M, Nio E et al (2019) CAMK2-Dependent signaling in neurons is essential for survival. J Neurosci 39:5424\u20135439. https:\/\/doi.org\/10.1523\/JNEUROSCI.1341-18.2019","journal-title":"J Neurosci"},{"key":"2171_CR98","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/cercor\/11.12.1191","volume":"11","author":"CH Chan","year":"2001","unstructured":"Chan CH, Godinho LN, Thomaidou D, Tan SS, Gulisano M, Parnavelas JG (2001) Emx1 is a marker for pyramidal neurons of the cerebral cortex. Cereb Cortex 11:1191\u20131198. https:\/\/doi.org\/10.1093\/cercor\/11.12.1191","journal-title":"Cereb Cortex"},{"key":"2171_CR99","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.molcel.2022.03.007","volume":"82","author":"Y Shi","year":"2022","unstructured":"Shi Y, Kerry PS, Nanson JD, Bosanac T, Sasaki Y, Krauss R et al (2022) Structural basis of SARM1 activation, substrate recognition, and inhibition by small molecules. Mol Cell 82:1643\u20131659e10. https:\/\/doi.org\/10.1016\/j.molcel.2022.03.007","journal-title":"Mol Cell"},{"key":"2171_CR100","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1093\/brain\/awab184","volume":"144","author":"T Bosanac","year":"2021","unstructured":"Bosanac T, Hughes RO, Engber T, Devraj R, Brearley A, Danker K et al (2021) Pharmacological SARM1 Inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy. Brain 144:3226\u20133238. https:\/\/doi.org\/10.1093\/brain\/awab184","journal-title":"Brain"},{"key":"2171_CR101","doi-asserted-by":"publisher","first-page":"108588","DOI":"10.1016\/j.celrep.2020.108588","volume":"34","author":"RO Hughes","year":"2021","unstructured":"Hughes RO, Bosanac T, Mao X, Engber TM, DiAntonio A, Milbrandt J et al (2021) Small molecule SARM1 inhibitors recapitulate the SARM1-\/- phenotype and allow recovery of a metastable pool of axons fated to degenerate. Cell Rep 34:108588. https:\/\/doi.org\/10.1016\/j.celrep.2020.108588","journal-title":"Cell Rep"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02171-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02171-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02171-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:14:35Z","timestamp":1766150075000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-025-02171-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2171"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02171-0","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were approved by the Centre for Phenogenomics Animal Care (TCP) Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare the following financial interests\/personal relationships which may be considered as potential competing interests: Russell J. Schachar holds ownership interest (including patents) in Ehave. No potential conflicts of interest were disclosed by the other authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"254"}}